Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

GrandioSO x-tra

K-Number: K181312 · 2018-08-22

ApplicantVoco GmbH
Decision Date2018-08-22
Product CodeEBF
Advisory CommitteeDE
DecisionSubstantially Equivalent

Device Summary

GrandioSO x-tra is a medical device manufactured by Voco GmbH. It received FDA 510(k) clearance on 2018-08-22 under approval number K181312. The device is classified under product code EBF. It was reviewed by the DE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the GrandioSO x-tra?

GrandioSO x-tra is a medical device that received FDA 510(k) clearance on 2018-08-22. It is manufactured by Voco GmbH. The 510(k) number is K181312.

When was GrandioSO x-tra approved by the FDA?

GrandioSO x-tra received FDA 510(k) clearance on 2018-08-22, under approval number K181312.

What company makes GrandioSO x-tra?

GrandioSO x-tra is manufactured by Voco GmbH.

What is the FDA product code for GrandioSO x-tra?

The FDA product code for GrandioSO x-tra is EBF.

Other Devices by Voco GmbH

View all 29 devices →

Related Devices (Code: EBF)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.